Table 4.
Clinical profile and outcome of pregnant women who exhibited abnormal NST after PDSA cycle one
Patient got NST done in < 4 h (n = 1) | Patient got NST done in > 4 h (n = 3) | |||
---|---|---|---|---|
Parameters | Patient 1 | Patient 1 | Patient 2 | Patient 3 |
Age (years) | 28 | 24 | 32 | 29 |
Gravida/parity | G3P1001 | G1P0000 | G2P1001 | G3P0020 |
Indication of NST | Decreased fetal movement for two days | Fetal growth restriction | Pre-eclampsia | Overt diabetes on insulin |
Period of Gestation | 40 weeks 1 days | 34 weeks 0 days | 36 weeks 5 days | 35 weeks 1 days |
Intervention done | Emergency LSCS | Induced with dinoprostone gel | Induced with dinoprostone gel | Induced with dinoprostone gel |
Mode of Delivery | Cesarean section | Preterm vaginal delivery | Preterm vaginal delivery | Cesarean section |
Indication of LSCS | Fetal bradycardia | – | – | Thick meconium stained liquor with fetal bradycardia |
Fetal outcome APGAR score Birth weight |
5,6 2800gms |
7,8 1270gms |
7,8 2510gms |
6,7 2200gms |
NICU admission | On continuous positive airway pressure for 2 days | Kept for 24 h in view of tachypnea | Kept for 24 h in view of tachypnea | Kept for 36 h in view of hypoglycaemia |